Even with increasingly effective treatments and glucose monitors, most individuals with type 1 diabetes still cannot achieve recommended glucose control goals. Many experts believe that the best near-term solution for patients will be a system that can independently restore insulin and glucose balance.
“Artificial pancreas systems will be the most revolutionary advance in diabetes care since the discovery of insulin,” said Aaron Kowalski, PhD, a vice president at the Juvenile Diabetes Research Foundation (JDRF), a global organization that funds type 1 diabetes research.
Hampton T. Fully Automated Artificial Pancreas Finally Within Reach. JAMA. 2014;311(22):2260–2261. doi:10.1001/jama.2014.6386
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: